spacer
spacer

PDBsum entry 1cu1

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
1cu1

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
645 a.a.
Ligands
PO4 ×2
Metals
_ZN ×2
Waters ×268
PDB id:
1cu1
Name: Hydrolase
Title: Crystal structure of an enzyme complex from hepatitis c virus
Structure: Protein (protease/helicase ns3). Chain: a, b. Engineered: yes
Source: Hepatitis c virus. Organism_taxid: 11103. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.50Å     R-factor:   0.200     R-free:   0.260
Authors: N.Yao,P.C.Weber
Key ref:
N.Yao et al. (1999). Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure, 7, 1353-1363. PubMed id: 10574797 DOI: 10.1016/S0969-2126(00)80025-8
Date:
20-Aug-99     Release date:   23-Aug-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P26663  (POLG_HCVBK) -  Genome polyprotein from Hepatitis C virus genotype 1b (isolate BK)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
645 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 18 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
RNA(n)
+ ribonucleoside 5'-triphosphate
= RNA(n+1)
Bound ligand (Het Group name = PO4)
matches with 55.56% similarity
+ diphosphate
   Enzyme class 2: E.C.3.4.21.98  - hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 3: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 4: E.C.3.6.1.15  - nucleoside-triphosphate phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
ribonucleoside 5'-triphosphate
+ H2O
= ribonucleoside 5'-diphosphate
+ phosphate
+ H(+)
Bound ligand (Het Group name = PO4)
corresponds exactly
   Enzyme class 5: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate + H+
ATP
+ H2O
= ADP
+ phosphate
+ H(+)
Bound ligand (Het Group name = PO4)
corresponds exactly
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/S0969-2126(00)80025-8 Structure 7:1353-1363 (1999)
PubMed id: 10574797  
 
 
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
N.Yao, P.Reichert, S.S.Taremi, W.W.Prosise, P.C.Weber.
 
  ABSTRACT  
 
BACKGROUND: Hepatitis C virus (HCV) currently infects approximately 3% of the world's population. HCV RNA is translated into a polyprotein that during maturation is cleaved into functional components. One component, nonstructural protein 3 (NS3), is a 631-residue bifunctional enzyme with protease and helicase activities. The NS3 serine protease processes the HCV polyprotein by both cis and trans mechanisms. The structural aspects of cis processing, the autoproteolysis step whereby the protease releases itself from the polyprotein, have not been characterized. The structural basis for inclusion of protease and helicase activities in a single polypeptide is also unknown. RESULTS: We report here the 2.5 A resolution structure of an engineered molecule containing the complete NS3 sequence and the protease activation domain of nonstructural protein 4A (NS4A) in a single polypeptide chain (single chain or scNS3-NS4A). In the molecule, the helicase and protease domains are segregated and connected by a single strand. The helicase necleoside triphosphate and RNA interaction sites are exposed to solvent. The protease active site of scNS3-NS4A is occupied by the NS3 C terminus, which is part of the helicase domain. Thus, the intramolecular complex shows one product of NS3-mediated cleavage at the NS3-NS4A junction of the HCV polyprotein bound at the protease active site. CONCLUSIONS: The scNS3-NS4A structure provides the first atomic view of polyprotein cis processing. Both local and global structural rearrangements follow the cis cleavage reaction, and large segments of the polyprotein can be folded prior to proteolytic processing. That the product complex of the cis cleavage reaction exists in a stable molecular conformation suggests autoinhibition and substrate-induced activation mechanisms for regulation of NS3 protease activity.
 
  Selected figure(s)  
 
Figure 8.
Figure 8. HCV polyprotein processing in the nonstructural region. Nonstructural proteins NS3, NS4A, NS4B, NS5A and NS5B are colored purple, red, green, pink and orange, respectively. (a) Attachment of the 1984-residue polyprotein to the membrane. (b) NS4A activation and folding of the NS3 N terminus. (c) Subsequent cleavage reactions. To highlight the fact that the sequence of cleavage reactions has not been firmly established, the N terminus of the polyprotein substrate is dotted and the schematic diagrams are enclosed in a box. (d) The release of NS4B and NS5A and formation of the replication complex core.
 
  The above figure is reprinted by permission from Cell Press: Structure (1999, 7, 1353-1363) copyright 1999.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  21470343 K.Morikawa, C.M.Lange, J.Gouttenoire, E.Meylan, V.Brass, F.Penin, and D.Moradpour (2011).
Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
  J Viral Hepat, 18, 305-315.  
21194118 M.Geitmann, G.Dahl, and U.H.Danielson (2011).
Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors.
  J Mol Recognit, 24, 60-70.  
20978807 S.A.Shiryaev, A.V.Chernov, T.N.Shiryaeva, A.E.Aleshin, and A.Y.Strongin (2011).
The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicase.
  Arch Virol, 156, 313-318.  
21056040 T.Shimakami, C.Welsch, D.Yamane, D.R.McGivern, M.Yi, S.Zeuzem, and S.M.Lemon (2011).
Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus.
  Gastroenterology, 140, 667-675.  
20108979 C.A.Belon, Y.D.High, T.I.Lin, F.Pauwels, and D.N.Frick (2010).
Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.
  Biochemistry, 49, 1822-1832.  
20225153 D.N.Frick, O.Ginzburg, and A.M.Lam (2010).
A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.
  Methods Mol Biol, 587, 223-233.  
20080715 M.Gu, and C.M.Rice (2010).
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.
  Proc Natl Acad Sci U S A, 107, 521-528.
PDB codes: 3kqh 3kqk 3kql 3kqn 3kqu
  20161209 C.A.Belon, and D.N.Frick (2009).
Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.
  Future Virol, 4, 277-293.  
19515018 H.Tang, and H.Grisé (2009).
Cellular and molecular biology of HCV infection and hepatitis.
  Clin Sci (Lond), 117, 49-65.  
19199832 M.Krawczyk, M.Wasowska-Lukawska, I.Oszczapowicz, and A.M.Boguszewska-Chachulska (2009).
Amidinoanthracyclines - a new group of potential anti-hepatitis C virus compounds.
  Biol Chem, 390, 351-360.  
19793813 R.Assenberg, E.Mastrangelo, T.S.Walter, A.Verma, M.Milani, R.J.Owens, D.I.Stuart, J.M.Grimes, and E.J.Mancini (2009).
Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.
  J Virol, 83, 12895-12906.
PDB code: 2wv9
19088075 T.A.Jennings, S.G.Mackintosh, M.K.Harrison, D.Sikora, B.Sikora, B.Dave, A.J.Tackett, C.E.Cameron, and K.D.Raney (2009).
NS3 helicase from the hepatitis C virus can function as a monomer or oligomer depending on enzyme and substrate concentrations.
  J Biol Chem, 284, 4806-4814.  
19515772 T.Phan, R.K.Beran, C.Peters, I.C.Lorenz, and B.D.Lindenbach (2009).
Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.
  J Virol, 83, 8379-8395.  
19762279 T.Shimakami, R.E.Lanford, and S.M.Lemon (2009).
Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.
  Curr Opin Pharmacol, 9, 537-544.  
19010782 V.Serebrov, R.K.Beran, and A.M.Pyle (2009).
Establishing a mechanistic basis for the large kinetic steps of the NS3 helicase.
  J Biol Chem, 284, 2512-2521.  
18283103 B.Sikora, Y.Chen, C.F.Lichti, M.K.Harrison, T.A.Jennings, Y.Tang, A.J.Tackett, J.B.Jordan, J.Sakon, C.E.Cameron, and K.D.Raney (2008).
Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro.
  J Biol Chem, 283, 11516-11525.  
17942558 D.Luo, T.Xu, C.Hunke, G.Grüber, S.G.Vasudevan, and J.Lescar (2008).
Crystal structure of the NS3 protease-helicase from dengue virus.
  J Virol, 82, 173-183.
PDB code: 2vbc
18628290 J.Lara, R.M.Wohlhueter, Z.Dimitrova, and Y.E.Khudyakov (2008).
Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.
  Bioinformatics, 24, 1858-1864.  
18463735 N.A.Cannon, M.J.Donlin, X.Fan, R.Aurora, and J.E.Tavis (2008).
Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.
  PLoS ONE, 3, e2123.  
18670239 P.Halfon, M.Bourlière, H.Khiri, G.Pénaranda, A.Martineau, V.Oulès, J.Courcambeck, and P.Philibert (2008).
Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy.
  AIDS, 22, 1694-1696.  
18723512 R.K.Beran, and A.M.Pyle (2008).
Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase.
  J Biol Chem, 283, 29929-29937.  
18927624 V.Arumugaswami, R.Remenyi, V.Kanagavel, E.Y.Sue, T.Ngoc Ho, C.Liu, V.Fontanes, A.Dasgupta, and R.Sun (2008).
High-resolution functional profiling of hepatitis C virus genome.
  PLoS Pathog, 4, e1000182.  
18799730 V.Brass, J.M.Berke, R.Montserret, H.E.Blum, F.Penin, and D.Moradpour (2008).
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.
  Proc Natl Acad Sci U S A, 105, 14545-14550.  
18411324 W.Yang, Y.Zhao, J.Fabrycki, X.Hou, X.Nie, A.Sanchez, A.Phadke, M.Deshpande, A.Agarwal, and M.Huang (2008).
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors.
  Antimicrob Agents Chemother, 52, 2043-2052.  
18508894 Y.Ma, J.Yates, Y.Liang, S.M.Lemon, and M.Yi (2008).
NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly.
  J Virol, 82, 7624-7639.  
17581983 B.D.Lindenbach, B.M.Prágai, R.Montserret, R.K.Beran, A.M.Pyle, F.Penin, and C.M.Rice (2007).
The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication.
  J Virol, 81, 8905-8918.  
17289677 C.L.Johnson, D.M.Owen, and M.Gale (2007).
Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
  J Biol Chem, 282, 10792-10803.  
17487147 D.Moradpour, F.Penin, and C.M.Rice (2007).
Replication of hepatitis C virus.
  Nat Rev Microbiol, 5, 453-463.  
17084859 D.N.Frick, S.Banik, and R.S.Rypma (2007).
Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: magnesium provides a bridge for ATP to fuel unwinding.
  J Mol Biol, 365, 1017-1032.  
17949436 G.Dahl, A.Sandström, E.Akerblom, and U.H.Danielson (2007).
Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3.
  FEBS J, 274, 5979-5986.  
17447110 G.Wen, C.Chen, X.Luo, Y.Wang, C.Zhang, and Z.Pan (2007).
Identification and characterization of the NTPase activity of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) expressed in bacteria.
  Arch Virol, 152, 1565-1573.  
17869377 R.De Francesco, and A.Carfí (2007).
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
  Adv Drug Deliv Rev, 59, 1242-1262.  
17921146 R.K.Beran, V.Serebrov, and A.M.Pyle (2007).
The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate.
  J Biol Chem, 282, 34913-34920.  
17522203 T.L.Tellinghuisen, M.J.Evans, T.von Hahn, S.You, and C.M.Rice (2007).
Studying hepatitis C virus: making the best of a bad virus.
  J Virol, 81, 8853-8867.  
17373706 W.Zheng, J.C.Liao, B.R.Brooks, and S.Doniach (2007).
Toward the mechanism of dynamical couplings and translocation in hepatitis C virus NS3 helicase using elastic network model.
  Proteins, 67, 886-896.  
16699022 A.Lulla, V.Lulla, K.Tints, T.Ahola, and A.Merits (2006).
Molecular determinants of substrate specificity for Semliki Forest virus nonstructural protease.
  J Virol, 80, 5413-5422.  
16352601 M.Yi, X.Tong, A.Skelton, R.Chase, T.Chen, A.Prongay, S.L.Bogen, A.K.Saksena, F.G.Njoroge, R.L.Veselenak, R.B.Pyles, N.Bourne, B.A.Malcolm, and S.M.Lemon (2006).
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations.
  J Biol Chem, 281, 8205-8215.
PDB code: 2fm2
16407182 N.Appel, T.Schaller, F.Penin, and R.Bartenschlager (2006).
From structure to function: new insights into hepatitis C virus RNA replication.
  J Biol Chem, 281, 9833-9836.  
16675222 P.O.Johansson, M.Bäck, I.Kvarnström, K.Jansson, L.Vrang, E.Hamelink, A.Hallberg, A.Rosenquist, and B.Samuelsson (2006).
Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
  Bioorg Med Chem, 14, 5136-5151.  
17116245 R.J.Johnson, S.R.Lin, and R.T.Raines (2006).
A ribonuclease zymogen activated by the NS3 protease of the hepatitis C virus.
  FEBS J, 273, 5457-5465.  
16306038 S.G.Mackintosh, J.Z.Lu, J.B.Jordan, M.K.Harrison, B.Sikora, S.D.Sharma, C.E.Cameron, K.D.Raney, and J.Sakon (2006).
Structural and biological identification of residues on the surface of NS3 helicase required for optimal replication of the hepatitis C virus.
  J Biol Chem, 281, 3528-3535.
PDB code: 2f55
17254296 U.Kulkarni-Kale, S.G.Bhosle, G.S.Manjari, M.Joshi, S.Bansode, and A.S.Kolaskar (2006).
Curation of viral genomes: challenges, applications and the way forward.
  BMC Bioinformatics, 7, S12.  
17118133 Y.Ding, and D.Wilkins (2006).
Improving the Performance of SVM-RFE to Select Genes in Microarray Data.
  BMC Bioinformatics, 7, S12.  
16087668 C.Lin, C.A.Gates, B.G.Rao, D.L.Brennan, J.R.Fulghum, Y.P.Luong, J.D.Frantz, K.Lin, S.Ma, Y.Y.Wei, R.B.Perni, and A.D.Kwong (2005).
In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.
  J Biol Chem, 280, 36784-36791.  
15917225 C.Yon, T.Teramoto, N.Mueller, J.Phelan, V.K.Ganesh, K.H.Murthy, and R.Padmanabhan (2005).
Modulation of the nucleoside triphosphatase/RNA helicase and 5'-RNA triphosphatase activities of Dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase.
  J Biol Chem, 280, 27412-27419.  
16037945 G.Marceau, P.Lapierre, K.Béland, H.Soudeyns, and F.Alvarez (2005).
LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
  Hepatology, 42, 675-682.  
15767257 J.C.Ferreon, A.C.Ferreon, K.Li, and S.M.Lemon (2005).
Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.
  J Biol Chem, 280, 20483-20492.  
16051820 J.Wu, A.K.Bera, R.J.Kuhn, and J.L.Smith (2005).
Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing.
  J Virol, 79, 10268-10277.
PDB codes: 1yks 1ymf 5ffm
15528191 N.L.Korneeva, E.A.First, C.A.Benoit, and R.E.Rhoads (2005).
Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity.
  J Biol Chem, 280, 1872-1881.  
14766754 C.Lin, K.Lin, Y.P.Luong, B.G.Rao, Y.Y.Wei, D.L.Brennan, J.R.Fulghum, H.M.Hsiao, S.Ma, J.P.Maxwell, K.M.Cottrell, R.B.Perni, C.A.Gates, and A.D.Kwong (2004).
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms.
  J Biol Chem, 279, 17508-17514.  
15566499 D.Moradpour, and H.E.Blum (2004).
A primer on the molecular virology of hepatitis C.
  Liver Int, 24, 519-525.  
14585830 D.N.Frick, R.S.Rypma, A.M.Lam, and B.Gu (2004).
The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.
  J Biol Chem, 279, 1269-1280.  
15479787 D.N.Frick, R.S.Rypma, A.M.Lam, and C.M.Frenz (2004).
Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations.
  Nucleic Acids Res, 32, 5519-5528.  
15294075 F.Nishikawa, K.Funaji, K.Fukuda, and S.Nishikawa (2004).
In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
  Oligonucleotides, 14, 114-129.  
15087464 M.K.Levin, Y.H.Wang, and S.S.Patel (2004).
The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity.
  J Biol Chem, 279, 26005-26012.  
15268625 V.Brass, H.E.Blum, and D.Moradpour (2004).
Recent developments in target identification against hepatitis C virus.
  Expert Opin Ther Targets, 8, 295-307.  
12944414 A.M.Lam, D.Keeney, and D.N.Frick (2003).
Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action.
  J Biol Chem, 278, 44514-44524.  
12646587 A.Pause, G.Kukolj, M.Bailey, M.Brault, F.Dô, T.Halmos, L.Lagacé, R.Maurice, M.Marquis, G.McKercher, C.Pellerin, L.Pilote, D.Thibeault, and D.Lamarre (2003).
An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
  J Biol Chem, 278, 20374-20380.  
14627736 D.Liu, W.T.Windsor, and D.F.Wyss (2003).
Double-stranded DNA-induced localized unfolding of HCV NS3 helicase subdomain 2.
  Protein Sci, 12, 2757-2767.  
  12556211 F.Narjes, U.Koch, and C.Steinkühler (2003).
Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?
  Expert Opin Investig Drugs, 12, 153-163.  
12615931 J.A.Grobler, E.J.Markel, J.F.Fay, D.J.Graham, A.L.Simcoe, S.W.Ludmerer, E.M.Murray, G.Migliaccio, and O.A.Flores (2003).
Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase.
  J Biol Chem, 278, 16741-16746.  
12584342 K.J.Blight, J.A.McKeating, J.Marcotrigiano, and C.M.Rice (2003).
Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.
  J Virol, 77, 3181-3190.  
12917405 L.Vasiljeva, A.Merits, A.Golubtsov, V.Sizemskaja, L.Kääriäinen, and T.Ahola (2003).
Regulation of the sequential processing of Semliki Forest virus replicase polyprotein.
  J Biol Chem, 278, 41636-41645.  
12882616 M.P.Walker, N.Yao, and Z.Hong (2003).
Promising candidates for the treatment of chronic hepatitis C.
  Expert Opin Investig Drugs, 12, 1269-1280.  
12509436 M.Wang, K.K.Ng, M.M.Cherney, L.Chan, C.G.Yannopoulos, J.Bedard, N.Morin, N.Nguyen-Ba, M.H.Alaoui-Ismaili, R.C.Bethell, and M.N.James (2003).
Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition.
  J Biol Chem, 278, 9489-9495.
PDB codes: 1nhu 1nhv
12192066 A.Casbarra, F.D.Piaz, P.Ingallinella, S.Orrù, P.Pucci, A.Pessi, and E.Bianchi (2002).
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
  Protein Sci, 11, 2102-2112.  
11967294 B.M.Kümmerer, and C.M.Rice (2002).
Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.
  J Virol, 76, 4773-4784.  
12383770 D.Moradpour, V.Brass, R.Gosert, B.Wölk, and H.E.Blum (2002).
Hepatitis C: molecular virology and antiviral targets.
  Trends Mol Med, 8, 476-482.  
12325160 E.Bianchi, and A.Pessi (2002).
Inhibiting viral proteases: challenges and opportunities.
  Biopolymers, 66, 101-114.  
11839499 J.M.Caruthers, and D.B.McKay (2002).
Helicase structure and mechanism.
  Curr Opin Struct Biol, 12, 123-133.  
11969409 P.Ingallinella, D.Fattori, S.Altamura, C.Steinkühler, U.Koch, D.Cicero, R.Bazzo, R.Cortese, E.Bianchi, and A.Pessi (2002).
Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
  Biochemistry, 41, 5483-5492.  
11867545 P.S.Pang, E.Jankowsky, P.J.Planet, and A.M.Pyle (2002).
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.
  EMBO J, 21, 1168-1176.  
11841941 S.J.Archer, D.M.Camac, Z.J.Wu, N.A.Farrow, P.J.Domaille, Z.R.Wasserman, M.Bukhtiyarova, C.Rizzo, S.Jagannathan, L.J.Mersinger, and C.A.Kettner (2002).
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.
  Chem Biol, 9, 79-92.  
12415247 S.L.Tan, A.Pause, Y.Shi, and N.Sonenberg (2002).
Hepatitis C therapeutics: current status and emerging strategies.
  Nat Rev Drug Discov, 1, 867-881.  
11245202 A.Pessi (2001).
A personal account of the role of peptide research in drug discovery: the case of hepatitis C.
  J Pept Sci, 7, 2.  
15989494 B.W.Dymock (2001).
Emerging therapies for hepatitis C virus infection.
  Expert Opin Emerg Drugs, 6, 13-42.  
11557752 J.Schmidt-Mende, E.Bieck, T.Hugle, F.Penin, C.M.Rice, H.E.Blum, and D.Moradpour (2001).
Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase.
  J Biol Chem, 276, 44052-44063.  
11445467 M.A.Walker (2001).
Novel antiviral molecules.
  Drug Discov Today, 6, 747-749.  
10756044 N.Butkiewicz, N.Yao, W.Zhong, J.Wright-Minogue, P.Ingravallo, R.Zhang, J.Durkin, D.N.Standring, B.M.Baroudy, D.V.Sangar, S.M.Lemon, J.Y.Lau, and Z.Hong (2000).
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
  J Virol, 74, 4291-4301.  
10864644 V.C.Lai, W.Zhong, A.Skelton, P.Ingravallo, V.Vassilev, R.O.Donis, Z.Hong, and J.Y.Lau (2000).
Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virus.
  J Virol, 74, 6339-6347.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer